Imatinib Mesylate (Gleevec; STI571) in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed by Surgery

This study is ongoing, but not recruiting participants.

Study NCT00041197 Information provided by National Cancer Institute (NCI)

First Received: July 8, 2002 Last Updated: April 18, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	April 2018 (Final data collection date for primary outcome measure)